Trials / Completed
CompletedNCT03772509
Use of Introduction Mode to Improve Interactive Voice Response Surveys in Bangladesh and Tanzania
A Randomized Controlled Trial of Varying Introduction Mode to Improve Interactive Voice Response (IVR) Survey Performance in Bangladesh and Tanzania
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 1,511 (actual)
- Sponsor
- Johns Hopkins Bloomberg School of Public Health · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This study evaluates the effect of two different introduction modes on interactive voice response (IVR) survey cooperation, response, refusal, and contact rates, in Bangladesh and Tanzania.
Detailed description
Using random digit dialing (RDD) sampling techniques, participants were randomized to one of two introduction modes, followed by a noncommunicable disease (NCD) risk factor survey. The two modes were computer assisted telephone interview (CATI), in which a call-center employee read the introduction to a participant and received oral consent from them, before sending them the NCD risk factor survey via IVR, or the entire survey, including the introduction and consent, being obtained via IVR. In IVR surveys, participants use their touch tone key pad to answer pre-recorded questions. (i.e. If you are male, press 1; If you are female, press 2). This study was conducted in both Bangladesh and Tanzania.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | CATI | The participants in this arm were read the introduction and asked for consent by a call center employee using computer-assisted telephone interviewing and then were sent a noncommunicable disease risk factor survey via interactive voice response. This mode was used to motivate participants to complete the survey. |
Timeline
- Start date
- 2017-06-14
- Primary completion
- 2017-08-18
- Completion
- 2017-08-18
- First posted
- 2018-12-11
- Last updated
- 2023-05-22
Locations
2 sites across 2 countries: Bangladesh, Tanzania
Source: ClinicalTrials.gov record NCT03772509. Inclusion in this directory is not an endorsement.